1. Adstamongkonkul D, Hess DC: Ischemic Conditioning and neonatal hypoxic ischemic encephalopathy: a literature review. Cond Med 2017, 1:9-16.
2. Greco P, Nencini G, Piva I, Scioscia M, Volta CA, Spadaro S, Neri M, Bonaccorsi G, Greco F, Cocco I, et al: Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg 2020, 120:277-288.
3. Altamentova S, Rumajogee P, Hong J, Beldick SR, Park SJ, Yee A, Fehlings MG: Methylprednisolone Reduces Persistent Post-ischemic Inflammation in a Rat Hypoxia-Ischemia Model of Perinatal Stroke. Transl Stroke Res 2020, 11:1117-1136.
4. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, et al: Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375:1969-1987.
5. Douglas-Escobar M, Weiss MD: Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr 2015, 169:397-403.
6. Higgins RD, Raju T, Edwards AD, Azzopardi DV, Bose CL, Clark RH, Ferriero DM, Guillet R, Gunn AJ, Hagberg H, et al: Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop. J Pediatr 2011, 159:851-858 e851.
7. Algra SO, Groeneveld KM, Schadenberg AW, Haas F, Evens FC, Meerding J, Koenderman L, Jansen NJ, Prakken BJ: Cerebral ischemia initiates an immediate innate immune response in neonates during cardiac surgery. J Neuroinflammation 2013, 10:24.
8. Wang LW, Chang YC, Lin CY, Hong JS, Huang CC: Low-dose lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white matter injury in the immature brain. Pediatr Res 2010, 68:41-47.
9. Iadecola C, Anrather J: The immunology of stroke: from mechanisms to translation. Nat Med 2011, 17:796-808.
10. Hagberg H, Mallard C, Ferriero DM, Vannucci SJ, Levison SW, Vexler ZS, Gressens P: The role of inflammation in perinatal brain injury. Nat Rev Neurol 2015, 11:192-208.
11. Bhalala US, Koehler RC, Kannan S: Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain. Front Pediatr 2014, 2:144.
12. Lyu J, Jiang X, Leak RK, Shi Y, Hu X, Chen J: Microglial Responses to Brain Injury and Disease: Functional Diversity and New Opportunities. Transl Stroke Res 2021, 12:474-495.
13. McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD, Van der Ploeg LH: Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 1997, 46:426-434.
14. Egerod KL, Holst B, Petersen PS, Hansen JB, Mulder J, Hokfelt T, Schwartz TW: GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue. Mol Endocrinol 2007, 21:1685-1698.
15. Jackson VR, Nothacker HP, Civelli O: GPR39 receptor expression in the mouse brain. Neuroreport 2006, 17:813-816.
16. Hershfinkel M: The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease. Int J Mol Sci 2018, 19.
17. Zhao H, Qiao J, Zhang S, Zhang H, Lei X, Wang X, Deng Z, Ning L, Cao Y, Guo Y, et al: GPR39 marks specific cells within the sebaceous gland and contributes to skin wound healing. Sci Rep 2015, 5:7913.
18. Sunuwar L, Medini M, Cohen L, Sekler I, Hershfinkel M: The zinc sensing receptor, ZnR/GPR39, triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis. Philos Trans R Soc Lond B Biol Sci 2016, 371.
19. Gilad D, Shorer S, Ketzef M, Friedman A, Sekler I, Aizenman E, Hershfinkel M: Homeostatic regulation of KCC2 activity by the zinc receptor mZnR/GPR39 during seizures. Neurobiol Dis 2015, 81:4-13.
20. Ding Q, Li H, Tian X, Shen Z, Wang X, Mo F, Huang J, Shen H: Zinc and imipramine reverse the depression-like behavior in mice induced by chronic restraint stress. J Affect Disord 2016, 197:100-106.
21. Mlyniec K, Starowicz G, Gawel M, Frackiewicz E, Nowak G: Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist. J Affect Disord 2016, 201:179-184.
22. Moran BM, Abdel-Wahab YH, Vasu S, Flatt PR, McKillop AM: GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis. Acta Diabetol 2016, 53:279-293.
23. Jiang Y, Li T, Wu Y, Xu H, Xie C, Dong Y, Zhong L, Wang Z, Zhao H, Zhou Y, et al: GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression. J Dent Res 2020, 99:949-958.
24. Mero M, Asraf H, Sekler I, Taylor KM, Hershfinkel M: Corrigendum to "ZnR/GPR39 upregulation of K(+)/Cl(-)-cotransporter 3 in tamoxifen resistant breast cancer cells" [Cell Calcium 81 (2019) 12-20]. Cell Calcium 2019, 83:102077.
25. Jing W, Sun W, Zhang N, Zhao C, Yan X: The protective effects of the GPR39 agonist TC-G 1008 against TNF-alpha-induced inflammation in human fibroblast-like synoviocytes (FLSs). Eur J Pharmacol 2019, 865:172663.
26. Xu Y, Wang M, Xie Y, Jiang Y, Liu M, Yu S, Wang B, Liu Q: Activation of GPR39 with the agonist TC-G 1008 ameliorates ox-LDL-induced attachment of monocytes to endothelial cells. Eur J Pharmacol 2019, 858:172451.
27. Muneoka S, Goto M, Kadoshima-Yamaoka K, Kamei R, Terakawa M, Tomimori Y: G protein-coupled receptor 39 plays an anti-inflammatory role by enhancing IL-10 production from macrophages under inflammatory conditions. Eur J Pharmacol 2018, 834:240-245.
28. Mo F, Tang Y, Du P, Shen Z, Yang J, Cai M, Zhang Y, Li H, Shen H: GPR39 protects against corticosterone-induced neuronal injury in hippocampal cells through the CREB-BDNF signaling pathway. J Affect Disord 2020, 272:474-484.
29. Dittmer S, Sahin M, Pantlen A, Saxena A, Toutzaris D, Pina AL, Geerts A, Golz S, Methner A: The constitutively active orphan G-protein-coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelium-derived growth factor. J Biol Chem 2008, 283:7074-7081.
30. Sanchez-Temprano A, Relova JL, Camina JP, Pazos Y: Concurrent Akt, ERK1/2 and AMPK Activation by Obestatin Inhibits Apoptotic Signaling Cascades on Nutrient-Deprived PC12 Cells. Cell Mol Neurobiol 2021.
31. Rice JE, 3rd, Vannucci RC, Brierley JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981, 9:131-141.
32. Lioutas VA, Alfaro-Martinez F, Bedoya F, Chung CC, Pimentel DA, Novak V: Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke. Transl Stroke Res 2015, 6:264-275.
33. Hu X, Li S, Doycheva DM, Huang L, Lenahan C, Liu R, Huang J, Xie S, Tang J, Zuo G, Zhang JH: Rh-CSF1 attenuates neuroinflammation via the CSF1R/PLCG2/PKCepsilon pathway in a rat model of neonatal HIE. J Neuroinflammation 2020, 17:182.
34. Griemert EV, Recarte Pelz K, Engelhard K, Schafer MK, Thal SC: PAI-1 but Not PAI-2 Gene Deficiency Attenuates Ischemic Brain Injury After Experimental Stroke. Transl Stroke Res 2019, 10:372-380.
35. Tulsulkar J, Glueck B, Hinds TD, Jr., Shah ZA: Ginkgo biloba Extract Prevents Female Mice from Ischemic Brain Damage and the Mechanism Is Independent of the HO1/Wnt Pathway. Transl Stroke Res 2016, 7:120-131.
36. Zhang Y, Zhang X, Wei Q, Leng S, Li C, Han B, Bai Y, Zhang H, Yao H: Activation of Sigma-1 Receptor Enhanced Pericyte Survival via the Interplay Between Apoptosis and Autophagy: Implications for Blood-Brain Barrier Integrity in Stroke. Transl Stroke Res 2020, 11:267-287.
37. Zhang Y, Ding Y, Lu T, Zhang Y, Xu N, Yu L, McBride DW, Flores JJ, Tang J, Zhang JH: Bliverdin reductase-A improves neurological function in a germinal matrix hemorrhage rat model. Neurobiol Dis 2018, 110:122-132.
38. Zhang Y, Xu N, Ding Y, Doycheva DM, Zhang Y, Li Q, Flores J, Haghighiabyaneh M, Tang J, Zhang JH: Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic-ischemic encephalopathy. Cell Death Dis 2019, 10:97.
39. Depoortere I: GI functions of GPR39: novel biology. Curr Opin Pharmacol 2012, 12:647-652.
40. Rychlik M, Mlyniec K: Zinc-mediated Neurotransmission in Alzheimer's Disease: A Potential Role of the GPR39 in Dementia. Curr Neuropharmacol 2020, 18:2-13.
41. Chen NN, Zhao DJ, Sun YX, Wang DD, Ni H: Long-Term Effects of Zinc Deficiency and Zinc Supplementation on Developmental Seizure-Induced Brain Damage and the Underlying GPR39/ZnT-3 and MBP Expression in the Hippocampus. Front Neurosci 2019, 13:920.
42. Higashi Y, Aratake T, Shimizu S, Shimizu T, Saito M: [Brain zinc dyshomeostasis and glial cells in ischemic stroke]. Nihon Yakurigaku Zasshi 2019, 154:138-142.
43. Chai X, Zhang W, Chang B, Feng X, Song J, Li L, Yu C, Zhao J, Si H: GPR39 agonist TC-G 1008 promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Artif Cells Nanomed Biotechnol 2019, 47:3569-3576.
44. Lu H, Wang D, Li H, Zhong J, Lin Y, Xu X, Wang B: GPR39 agonist TC-G 1008 ameliorates IL-1beta-induced chondrocyte senescence. Artif Cells Nanomed Biotechnol 2019, 47:2612-2617.
45. Satianrapapong W, Pongkorpsakol P, Muanprasat C: A G-protein coupled receptor 39 agonist stimulates proliferation of keratinocytes via an ERK-dependent pathway. Biomed Pharmacother 2020, 127:110160.
46. Pongkorpsakol P, Buasakdi C, Chantivas T, Chatsudthipong V, Muanprasat C: An agonist of a zinc-sensing receptor GPR39 enhances tight junction assembly in intestinal epithelial cells via an AMPK-dependent mechanism. Eur J Pharmacol 2019, 842:306-313.
47. Shan W, Qi J, Li C, Nie X: Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells. Arch Biochem Biophys 2019, 677:108164.
48. Cuzon Carlson VC, Ford MM, Carlson TL, Lomniczi A, Grant KA, Ferguson B, Cervera-Juanes RP: Modulation of Gpr39, a G-protein coupled receptor associated with alcohol use in non-human primates, curbs ethanol intake in mice. Neuropsychopharmacology 2019, 44:1103-1113.
49. Starowicz G, Jarosz M, Frackiewicz E, Grzechnik N, Ostachowicz B, Nowak G, Mlyniec K: Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008. J Affect Disord 2019, 245:325-334.
50. Mero M, Asraf H, Sekler I, Taylor KM, Hershfinkel M: ZnR/GPR39 upregulation of K(+)/Cl(-)-cotransporter 3 in tamoxifen resistant breast cancer cells. Cell Calcium 2019, 81:12-20.
51. Xie F, Liu H, Zhu YH, Qin YR, Dai Y, Zeng T, Chen L, Nie C, Tang H, Li Y, et al: Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer 2011, 11:86.
52. Fjellstrom O, Larsson N, Yasuda S, Tsuchida T, Oguma T, Marley A, Wennberg-Huldt C, Hovdal D, Fukuda H, Yoneyama Y, et al: Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents. PLoS One 2015, 10:e0145849.
53. Zhu D, Su Y, Zheng Y, Fu B, Tang L, Qin YX: Zinc regulates vascular endothelial cell activity through zinc-sensing receptor ZnR/GPR39. Am J Physiol Cell Physiol 2018, 314:C404-C414.
54. Nishida K, Hasegawa A, Yamasaki S, Uchida R, Ohashi W, Kurashima Y, Kunisawa J, Kimura S, Iwanaga T, Watarai H, et al: Mast cells play role in wound healing through the ZnT2/GPR39/IL-6 axis. Sci Rep 2019, 9:10842.
55. Zhang JF, Zhang YL, Wu YC: The Role of Sirt1 in Ischemic Stroke: Pathogenesis and Therapeutic Strategies. Front Neurosci 2018, 12:833.
56. Chen M, Wang Z, Zhou W, Lu C, Ji T, Yang W, Jin Z, Tian Y, Lei W, Wu S, et al: SIRT1/PGC-1alpha signaling activation by mangiferin attenuates cerebral hypoxia/reoxygenation injury in neuroblastoma cells. Eur J Pharmacol 2021, 907:174236.
57. Luo Y, Chen H, Tsoi B, Wang Q, Shen J: Danggui-Shaoyao-San (DSS) Ameliorates Cerebral Ischemia-Reperfusion Injury via Activating SIRT1 Signaling and Inhibiting NADPH Oxidases. Front Pharmacol 2021, 12:653795.
58. Zhou F, Wang YK, Zhang CG, Wu BY: miR-19a/b-3p promotes inflammation during cerebral ischemia/reperfusion injury via SIRT1/FoxO3/SPHK1 pathway. J Neuroinflammation 2021, 18:122.
59. Chen SD, Yang DI, Lin TK, Shaw FZ, Liou CW, Chuang YC: Roles of oxidative stress, apoptosis, PGC-1alpha and mitochondrial biogenesis in cerebral ischemia. Int J Mol Sci 2011, 12:7199-7215.
60. Zhu HR, Wang ZY, Zhu XL, Wu XX, Li EG, Xu Y: Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1alpha expression in experimental stroke. Neuropharmacology 2010, 59:70-76.
61. Huang J, Liu W, Doycheva DM, Gamdzyk M, Lu W, Tang J, Zhang JH: Ghrelin attenuates oxidative stress and neuronal apoptosis via GHSR-1alpha/AMPK/Sirt1/PGC-1alpha/UCP2 pathway in a rat model of neonatal HIE. Free Radic Biol Med 2019, 141:322-337.
62. Salman M, Tabassum H, Parvez S: Tannic Acid Provides Neuroprotective Effects Against Traumatic Brain Injury Through the PGC-1alpha/Nrf2/HO-1 Pathway. Mol Neurobiol 2020, 57:2870-2885.
63. Gao Y, Fu R, Wang J, Yang X, Wen L, Feng J: Resveratrol mitigates the oxidative stress mediated by hypoxic-ischemic brain injury in neonatal rats via Nrf2/HO-1 pathway. Pharm Biol 2018, 56:440-449.